Literature DB >> 10667242

Rational development of cell-penetrating high affinity SH3 domain binding peptides that selectively disrupt the signal transduction of Crk family adapters. Amgen Peptide Technology Group.

C Kardinal1, G Posern, J Zheng, B S Knudsen, I Moarefi, S M Feller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10667242     DOI： 10.1111/j.1749-6632.1999.tb09439.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

Review 1.  Viral infection and human disease--insights from minimotifs.

Authors:  Krishna Kadaveru; Jay Vyas; Martin R Schiller
Journal:  Front Biosci       Date:  2008-05-01

Review 2.  SH3 domains: modules of protein-protein interactions.

Authors:  Natalya Kurochkina; Udayan Guha
Journal:  Biophys Rev       Date:  2012-06-20

3.  Promiscuous binding at the crossroads of numerous cancer pathways: insight from the binding of glutaminase interacting protein with glutaminase L.

Authors:  David L Zoetewey; Mohiuddin Ovee; Monimoy Banerjee; Rajagopalan Bhaskaran; Smita Mohanty
Journal:  Biochemistry       Date:  2011-04-06       Impact factor: 3.162

4.  Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.

Authors:  G Sriram; W Jankowski; C Kasikara; C Reichman; T Saleh; K-Q Nguyen; J Li; P Hornbeck; K Machida; T Liu; H Li; C G Kalodimos; R B Birge
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.